Literature DB >> 2459102

Identification of surfactant proteolipid SP-B in human surfactant and fetal lung.

T E Weaver1, V K Sarin, N Sawtell, W M Hull, J A Whitsett.   

Abstract

Surfactant proteolipid (SP-B) is one of several hydrophobic peptides detected in organic extracts of pulmonary surfactant and associated with the dramatic surface-active properties of surfactant phospholipids. In the present study human SP-B was identified as a protein with a relative molecular weight (Mr) of 7,500-8,000 under reducing conditions; protein of Mr 18,000 was detected under nonreducing conditions by immunoblot analysis of organic extracts of bovine and human surfactant utilizing an antiserum directed against a 60-amino acid synthetic SP-B peptide. This peptide antiserum was subsequently used to identify SP-B in explant cultures of 18- to 23-wk gestation human fetal lung. Immunoprecipitation of explants labeled with [35S]methionine after 48 h of culture identified proteins of Mr 40,000-42,000, 25,000, and 18,000 after electrophoresis under nonreducing conditions. The Mr 18,000 form was reduced to Mr 7,500-8,000 in the presence of beta-mercaptoethanol. These molecular forms likely represent the SP-B precursor protein, a proteolytic intermediate, and the mature SP-B peptide, respectively. Immunocytochemistry with the peptide antiserum localized SPL(Phe) in granular inclusions in the apical region of type II-like epithelial cells, a pattern of staining similar to that observed for the major surfactant-associated protein of Mr 26,000-38,000 (SP-A). SP-B is a novel pulmonary surfactant-associated protein that is synthesized by the human alveolar type II epithelial cell as an Mr 40,000-42,000 precursor that is subsequently proteolytically processed to Mr 7,500-8,000.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459102     DOI: 10.1152/jappl.1988.65.2.982

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 2.  Pulmonary surfactant and its apoproteins.

Authors:  S Hawgood; J A Clements
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Dach1 mutant mice bear no gross abnormalities in eye, limb, and brain development and exhibit postnatal lethality.

Authors:  R J Davis; W Shen; Y I Sandler; M Amoui; P Purcell; R Maas; C N Ou; H Vogel; A L Beaudet; G Mardon
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.

Authors:  Lemme P Kebaabetswe; Anoria K Haick; Marina A Gritsenko; Thomas L Fillmore; Rosalie K Chu; Samuel O Purvine; Bobbie-Jo Webb-Robertson; Melissa M Matzke; Richard D Smith; Katrina M Waters; Thomas O Metz; Tanya A Miura
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

5.  Surfactant protein B deficiency: radiographic manifestations.

Authors:  T E Herman; L M Nogee; W H McAlister; L P Dehner
Journal:  Pediatr Radiol       Date:  1993

6.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

Authors:  T J Gregory; W J Longmore; M A Moxley; J A Whitsett; C R Reed; A A Fowler; L D Hudson; R J Maunder; C Crim; T M Hyers
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein.

Authors:  A Keller; H R Eistetter; T Voss; K P Schäfer
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

8.  Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain.

Authors:  R Bruni; H W Taeusch; A J Waring
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 9.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.